NeuroSigma, Inc

Los Angeles,  CA 
United States
  • Booth: 441

NeuroSigma is a California-based life sciences company commercializing Trigeminal Nerve Stimulation (TNS) therapies for treating neurologic and neuropsychiatric disorders. In April 2019, NeuroSigma’s non-invasive Monarch® external Trigeminal Nerve Stimulation (eTNS®) System became the first-ever medical device to receive FDA clearance for treating pediatric ADHD.

For technical assistance with this webpage, please contact support